75 related articles for article (PubMed ID: 31045322)
1. Chromosomal gains of 12p and 1q are not associated with inferior outcome of pediatric and adolescent germ cell tumors.
Greimelmaier K; Calaminus G; Kristiansen G; Vokuhl C; Klapper W
Pediatr Blood Cancer; 2019 Aug; 66(8):e27777. PubMed ID: 31045322
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior.
Gupta S; Sholl LM; Yang Y; Osunkoya AO; Gordetsky JB; Cornejo KM; Michalova K; Maclean F; Dvindenko E; Snuderl M; Hirsch MS; Anderson WJ; Rowsey RA; Jimenez RE; Cheville JC; Sadow PM; Colecchia M; Ricci C; Ulbright TM; Berney DM; Acosta AM
J Pathol; 2024 Jan; 262(1):50-60. PubMed ID: 37792634
[TBL] [Abstract][Full Text] [Related]
3. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site.
Schraw JM; Sok P; Desrosiers TA; Janitz AE; Langlois PH; Canfield MA; Frazier AL; Plon SE; Lupo PJ; Poynter JN
Cancer; 2023 Oct; 129(20):3300-3308. PubMed ID: 37366624
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
[TBL] [Abstract][Full Text] [Related]
5. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
Gratias EJ; Dome JS; Jennings LJ; Chi YY; Tian J; Anderson J; Grundy P; Mullen EA; Geller JI; Fernandez CV; Perlman EJ
J Clin Oncol; 2016 Sep; 34(26):3189-94. PubMed ID: 27400937
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignant childhood germ cell tumors in relation to demographic, gestational, and perinatal characteristics.
Hall C; Ritz B; Cockburn M; Davidson TB; Heck JE
Cancer Epidemiol; 2017 Feb; 46():42-49. PubMed ID: 28013088
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study.
Hosny G; Ahmed OA; Ahmed RM; Fadel SA
Int J Surg Pathol; 2024 Feb; 32(1):66-74. PubMed ID: 37170541
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.
Cui J; Liu Y; Lv R; Yan W; Xu J; Li L; Du C; Yu T; Zhang S; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
Leukemia; 2024 Jun; 38(6):1299-1306. PubMed ID: 38609496
[TBL] [Abstract][Full Text] [Related]
9. Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers.
Pongratanakul P; Bremmer F; Pauls S; Poschmann G; Kresbach C; Parmaksiz F; Skowron MA; Fuß J; Stephan A; Paffenholz P; Stühler K; Schüller U; Ströbel P; Heidenreich A; Che Y; Albers P; Nettersheim D
Cancer Lett; 2024 Mar; 585():216673. PubMed ID: 38296184
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
Elmuti L; Amundson J; Oberman E; Kamat A; Sedig L; Lastra RR; Aldape K; Quezado M; Pratt DW; Cimino PJ; Abdullaev Z; Pytel P; Applebaum MA; Bennett JA
Int J Gynecol Pathol; 2024 Jan; 43(1):90-96. PubMed ID: 37046379
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal Germ-cell Tumors Relapse in a Male With Klinefelter Syndrome. Is Longer Surveillance Needed?
Stefanachi F; Affinita MC; Fichera G; Tagarelli A; De Corti F; Rea F; Bisogno G
J Pediatr Hematol Oncol; 2024 Apr; 46(3):e248-e250. PubMed ID: 38446472
[TBL] [Abstract][Full Text] [Related]
12. In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Lannes R; Samur M; Perrot A; Mazzotti C; Divoux M; Cazaubiel T; Leleu X; Schavgoulidze A; Chretien ML; Manier S; Adiko D; Orsini-Piocelle F; Lifermann F; Brechignac S; Gastaud L; Bouscary D; Macro M; Cleynen A; Mohty M; Munshi N; Corre J; Avet-Loiseau H
J Clin Oncol; 2023 Mar; 41(9):1695-1702. PubMed ID: 36343306
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets.
Bremmer F; Pongratanakul P; Skowron M; Che Y; Richter A; Küffer S; Reuter-Jessen K; Bohnenberger H; Pauls S; Kresbach C; Schüller U; Stühler K; Ströbel P; Albers P; Nettersheim D
Br J Cancer; 2023 Nov; 129(10):1580-1589. PubMed ID: 37726478
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MicroRNA-371-373 supports that a subset of spermatocytic tumors demonstrates biologic features similar to those of GCNIS-derived germ cell tumors.
Lobo J; Tavares NT; Jerónimo C; Henrique R; Dvindenko E; Cornejo KM; Berney DM; Ulbright TM; Gupta S; Acosta AM
Hum Pathol; 2024 May; 148():66-71. PubMed ID: 38782099
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
Gödicke S; Kresbach C; Ehlert M; Obrecht D; Altendorf L; Hack K; von Hoff K; Carén H; Melcher V; Kerl K; Englinger B; Filbin M; Pajtler KW; Gojo J; Pietsch T; Rutkowski S; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):23. PubMed ID: 38265527
[TBL] [Abstract][Full Text] [Related]
16. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
[TBL] [Abstract][Full Text] [Related]
17. Clonal diversification and histogenesis of malignant germ cell tumours.
Oliver TRW; Chappell L; Sanghvi R; Deighton L; Ansari-Pour N; Dentro SC; Young MD; Coorens THH; Jung H; Butler T; Neville MDC; Leongamornlert D; Sanders MA; Hooks Y; Cagan A; Mitchell TJ; Cortes-Ciriano I; Warren AY; Wedge DC; Heer R; Coleman N; Murray MJ; Campbell PJ; Rahbari R; Behjati S
Nat Commun; 2022 Aug; 13(1):4272. PubMed ID: 35953478
[TBL] [Abstract][Full Text] [Related]
18. Giant bilateral prepubertal-type teratomas in a postpubertal patient: An illustrative case and review of the literature.
Collins K; Anderson WJ; Hirsch MS; Ulbright TM; Acosta AM
Virchows Arch; 2024 Jan; ():. PubMed ID: 38165518
[TBL] [Abstract][Full Text] [Related]
19. Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.
Bhuta R; Shah R; Gell JJ; Poynter JN; Bagrodia A; Dicken BJ; Pashankar F; Frazier AL; Shaikh F
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30562. PubMed ID: 37449938
[TBL] [Abstract][Full Text] [Related]
20. Imaging of pediatric extragonadal pelvic soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pace E; Johnson TS; Kao SC; Parikh AK; Qi J; Rajderkar DA; Reid JR; Towbin AJ; States LJ
Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29966. PubMed ID: 36482882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
